The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-[(2-Difluoromethoxy-phenylamino)-methyl]-5-methyl-pyrido[2,3-d]pyrimidine-2,4-diamine ID: ALA347088
PubChem CID: 472852
Max Phase: Preclinical
Molecular Formula: C16H16F2N6O
Molecular Weight: 346.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(CNc2ccccc2OC(F)F)cnc2nc(N)nc(N)c12
Standard InChI: InChI=1S/C16H16F2N6O/c1-8-9(7-22-14-12(8)13(19)23-16(20)24-14)6-21-10-4-2-3-5-11(10)25-15(17)18/h2-5,7,15,21H,6H2,1H3,(H4,19,20,22,23,24)
Standard InChI Key: BKBLAMYQCCHEHS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
1.9417 -4.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5167 -3.9750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2292 -5.2167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9417 -3.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2292 -3.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5167 -4.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6625 -5.2125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6542 -3.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3667 -3.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2292 -4.7792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9417 -5.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8000 -3.9542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2250 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3750 -4.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5125 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0792 -3.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2250 -2.7375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2000 -5.2167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9500 -6.0125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.6542 -4.7667 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 -2.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9375 -3.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5042 -2.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9292 -2.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2125 -2.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 1 2 0
4 1 1 0
5 4 2 0
6 3 1 0
7 1 1 0
8 4 1 0
9 14 1 0
10 13 1 0
11 10 1 0
12 16 1 0
13 15 2 0
14 7 2 0
15 12 1 0
16 9 1 0
17 5 1 0
18 6 1 0
19 11 1 0
20 11 1 0
21 8 1 0
22 13 1 0
23 15 1 0
24 25 1 0
25 23 2 0
2 6 2 0
9 8 2 0
24 22 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.34Molecular Weight (Monoisotopic): 346.1354AlogP: 2.71#Rotatable Bonds: 5Polar Surface Area: 111.97Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.86CX LogP: 2.63CX LogD: 2.63Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.65Np Likeness Score: -1.38
References 1. Debnath AK.. (2002) Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase., 45 (1): [PMID:11754578 ] [10.1021/jm010360c ]